Key facts
- Paindrainer’s last known valuation is $7.3M (Dec 2023).
- It has raised $5.5M; the latest was Later Stage VC ($830K) in Mar 2025.
- Notable investors include Almi Invest, Christer Delcea, Christian Jansson, Mats Leifland, Medicon Village — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Paindrainer
- ·The full record, as it builds
Funding rounds
No funding rounds for Paindrainer are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Paindrainer
Developer of a web-based, drug-free self-management tool designed for chronic pain patients to improve their quality of life. The company's self-management tool utilizes advanced, multi-layer artificial intelligence, helps to track the pain triggers as well as pain protectors, and suggests how to plan the day to minimize the level of pain, enabling patients to achieve a maximum level of function at the lowest possible level of pain.
- Sector
- Healthcare
- HQ
- Lund, Sweden
- Founded
- 2018
- Employees
- 10
- Website
- paindrainer.com/
- Ownership
- Privately Held (backing)
Paindrainer doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Paindrainer shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Paindrainer in its N-PORT filings yet. We sweep new filings monthly.